Skip to content

BARINTHUS BIOTHERAPEUTICS PLC

BRNS

CIK 0001828185

← back to feed
Revenue (TTM)
$14.97M
−100.0% YoY Q1 Apr 2026
Net Income (TTM)
−$60.87M
−8.8% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$1.51
−5.8% YoY Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
-434.7%
Q1 Apr 2026
Net Margin
-406.6%
Q1 Apr 2026
Free Cash Flow (TTM)
−$36.08M
Q1 Apr 2026
Cash
$65.86M
Q1 Apr 2026
Total Debt
$159K
Q1 Apr 2026
Shares Outstanding
40.85M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings